Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Metastases to the Kidney: A Clinicopathologic Study of Forty Three cases with an Emphasis on Deceptive Features.

Mehra R, Hafez K, Stuart Wolf J Jr, Kunju LP, Wu AJ.

Histopathology. 2014 Nov 19. doi: 10.1111/his.12524. [Epub ahead of print]

PMID:
25406592
[PubMed - as supplied by publisher]
2.

Inflammatory myofibroblastic tumor of the bladder.

Alderman M, Kunju LP.

Arch Pathol Lab Med. 2014 Oct;138(10):1272-7. doi: 10.5858/arpa.2014-0274-CC.

PMID:
25268188
[PubMed - in process]
3.

Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.

Kunju LP, Carskadon S, Siddiqui J, Tomlins SA, Chinnaiyan AM, Palanisamy N.

Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):e32-40. doi: 10.1097/PAI.0000000000000095.

PMID:
25203299
[PubMed - in process]
4.

Urologic Pathology: CBS25-1 CLEAR CELL PAPILLARY RENAL CELL CARCINOMA.

Kunju LP.

Pathology. 2014 Oct;46 Suppl 2:S42. doi: 10.1097/01.PAT.0000454231.90619.5c.

PMID:
25188173
[PubMed - in process]
5.

Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial.

Palanisamy N, Tsodikov A, Yan W, Suleman K, Rittmaster R, Lucia SM, Chinnaiyan AM, Fleshner N, Kunju LP.

Urol Oncol. 2014 Aug 27. pii: S1078-1439(14)00272-5. doi: 10.1016/j.urolonc.2014.07.015. [Epub ahead of print]

PMID:
25175425
[PubMed - as supplied by publisher]
6.

The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.

Chakravarthi BV, Pathi SS, Goswami MT, Cieślik M, Zheng H, Nallasivam S, Arekapudi SR, Jing X, Siddiqui J, Athanikar J, Carskadon SL, Lonigro RJ, Kunju LP, Chinnaiyan AM, Palanisamy N, Varambally S.

Oncotarget. 2014 Aug 30;5(16):6654-69.

PMID:
25115393
[PubMed - in process]
Free PMC Article
7.

Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer.

Kozminski MA, Palapattu GS, Mehra R, Montgomery JS, Weizer AZ, Skolarus TA, Hollenbeck BK, Miller DC, He C, Tomlins S, Montie JE, Feng FY, Wood DP, Kunju LP, Morgan TM.

Urology. 2014 Aug;84(2):373-8. doi: 10.1016/j.urology.2014.03.037. Epub 2014 Jun 21.

PMID:
24958484
[PubMed - indexed for MEDLINE]
8.

Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.

Amin MB, Smith SC, Agaimy A, Argani P, Compérat EM, Delahunt B, Epstein JI, Eble JN, Grignon DJ, Hartmann A, Hes O, Hirsch MS, Jimenez RE, Kunju LP, Martignoni G, McKenney JK, Moch H, Montironi R, Paner GP, Rao P, Srigley JR, Tickoo SK, Reuter VE.

Am J Surg Pathol. 2014 Jul;38(7):871-4. doi: 10.1097/PAS.0000000000000222. No abstract available.

PMID:
24805860
[PubMed - indexed for MEDLINE]
9.

Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.

Warrick JI, Tsodikov A, Kunju LP, Chinnaiyan AM, Palapattu GS, Morgan TM, Alva A, Tomlins S, Wu A, Montgomery JS, Hafez KS, Wolf JS Jr, Weizer AZ, Mehra R.

Hum Pathol. 2014 Jun;45(6):1139-46. doi: 10.1016/j.humpath.2014.02.004. Epub 2014 Feb 20.

PMID:
24767860
[PubMed - indexed for MEDLINE]
10.

HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.

Smith SC, Palanisamy N, Zuhlke KA, Johnson AM, Siddiqui J, Chinnaiyan AM, Kunju LP, Cooney KA, Tomlins SA.

Am J Surg Pathol. 2014 May;38(5):615-26. doi: 10.1097/PAS.0000000000000090.

PMID:
24722062
[PubMed - indexed for MEDLINE]
11.

Uroplakin II outperforms uroplakin III in diagnostically challenging settings.

Smith SC, Mohanty SK, Kunju LP, Chang E, Chung F, Carvalho JC, Paner GP, Hansel DE, Luthringer DJ, de Peralta-Ventrurina MN, Amin MB.

Histopathology. 2014 Jul;65(1):132-8. doi: 10.1111/his.12360. Epub 2014 Feb 25.

PMID:
24382161
[PubMed - in process]
12.

Imaging appearance of renal epithelioid angiomyolipomas.

Ryan MJ, Francis IR, Cohan RH, Davenport MS, Weizer A, Hafez K, Kunju LP.

J Comput Assist Tomogr. 2013 Nov-Dec;37(6):957-61. doi: 10.1097/RCT.0b013e3182a77674.

PMID:
24270119
[PubMed - indexed for MEDLINE]
13.

Activating ESR1 mutations in hormone-resistant metastatic breast cancer.

Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, Kalyana-Sundaram S, Wang R, Ning Y, Hodges L, Gursky A, Siddiqui J, Tomlins SA, Roychowdhury S, Pienta KJ, Kim SY, Roberts JS, Rae JM, Van Poznak CH, Hayes DF, Chugh R, Kunju LP, Talpaz M, Schott AF, Chinnaiyan AM.

Nat Genet. 2013 Dec;45(12):1446-51. doi: 10.1038/ng.2823. Epub 2013 Nov 3.

PMID:
24185510
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.

Grivas PD, Day KC, Karatsinides A, Paul A, Shakir N, Owainati I, Liebert M, Kunju LP, Thomas D, Hussain M, Day ML.

Mol Med. 2013 Nov 8;19:367-76. doi: 10.2119/molmed.2013.00108.

PMID:
24166682
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.

Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Triche TJ, Malik R, Bedenis R, McGregor N, Ma T, Chen W, Han S, Jing X, Cao X, Wang X, Chandler B, Yan W, Siddiqui J, Kunju LP, Dhanasekaran SM, Pienta KJ, Feng FY, Chinnaiyan AM.

Nat Genet. 2013 Nov;45(11):1392-8. doi: 10.1038/ng.2771. Epub 2013 Sep 29.

PMID:
24076601
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.

Warrick JI, Tomlins SA, Carskadon SL, Young AM, Siddiqui J, Wei JT, Chinnaiyan AM, Kunju LP, Palanisamy N.

Mod Pathol. 2014 Apr;27(4):609-20. doi: 10.1038/modpathol.2013.169. Epub 2013 Sep 27.

PMID:
24072184
[PubMed - in process]
Free PMC Article
17.

Renal tumors: diagnostic and prognostic biomarkers.

Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H; ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1518-31. doi: 10.1097/PAS.0b013e318299f12e.

PMID:
24025522
[PubMed - indexed for MEDLINE]
18.

Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.

Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR; members of the ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1505-17. doi: 10.1097/PAS.0b013e31829a85d0.

PMID:
24025521
[PubMed - indexed for MEDLINE]
19.

The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.

Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, Montironi R, Srigley JR; Members of the ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1490-504. doi: 10.1097/PAS.0b013e318299f0fb.

PMID:
24025520
[PubMed - indexed for MEDLINE]
20.

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P; ISUP Renal Tumor Panel.

Am J Surg Pathol. 2013 Oct;37(10):1469-89. doi: 10.1097/PAS.0b013e318299f2d1.

PMID:
24025519
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk